Wyeth Consumer Healthcare Withdraws Its Marketing Authorisation Application For Ibuprofen/Diphenhydramine Hydrochloride Wyeth
WWW.MEDICALNEWSTODAY.COM - The European Medicines Agency has been formally notified by Wyeth Consumer Healthcare of its decision to withdraw its application for a centralised marketing authorisation for the medicine Ibuprofen/Diphenhydramine Hydrochloride Wyeth 200 mg/25 mg soft capsules. This medicine was intended to be used for the short-term treatment of mild to moderate pain in adults who experience sleeplessness as a…
From the Front Page
- Comments
- Tweets (11)
Tweets
Sorry there have been no tweets in the last 7 days.
